Displaying 81 - 90 of 243
Alternative Name: Antiestrogen ICI 182780; Fulvestrant
Active Status: No
User: Male
Mode: Yes
Delivery Type: Injectable
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: Femasys Inc
Project Stage: Phase I
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Contrel Research, Belgium, APCOR R&M, Belgium
Project Stage: Regulatory
Alternative Name: Fibroplant LNG14 (also LNG 20)
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Contrel Research, Belgium
Project Stage: Regulatory
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Meril Life Science Private Ltd
Project Stage: Marketed
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: Prosan International B.V.
Project Stage: Marketed
Active Status: No
User: Male
Mode: No
Delivery Type: Injectable
Developer: University of Washington, Focused Scientific
Project Stage: Pre-clinical
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Vaginal, Other
Project Stage: Compound ID/Selection
Active Status: No
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: University of Mumbai
Project Stage: Pre-clinical
Alternative Name: Sperm glycolytic enzyme
Target
Active Status: Yes
Mode: No
Developer: University of North Carolina at Chapel Hill, NICHD
Role in reproduction: Sperm Function
Project Stage: Target Validation
Pages
